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Purpose: This study was carried out to reduce the possibility
of high-order multiple gestations and the failure of embryo
transfer by determining their replacement date based on the
number and quality of 2-day embryos.
Methods: All zygotes were cocultured with cumulus cells
in 10 „l of YS medium containing 10% human follicular
fluid (hFF) for 48 or 96 hr. In period I, all embryos were
transferred on day 3 (1032 cycles). In period II, the embryos
were transferred on either day 3 or day 5 by determining
their replacement date based on the number and quality of
2-day embryos: there were 2701 patients in whom embryos
were replaced on day 3 (in the case that the number of zy-
gotes was less than eight and the number of good-quality
embryos was less than three) and 1952 patients less than
40 years old in whom embryos were replaced on day 5
(in the case that the number of zygotes was eight or more
and/or the number of good-quality embryos was three or
more). On the other hand, patients who were 40 years old or
more were alloted to day 3 transfer cycles, regardless of the
number and quality of the 2-day embryos, due to the pos-
sibility of their not producing blastocyst-stage embryos in
vitro.
Results: The number of embryos transferred in period II
was 2.9 § 0.6, while that in period I was 3.7 § 0.5. The
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multiple pregnancy rate was significantly decreased in pe-
riod II (30.7%) compared to that (49.6%) in period I, while
the pregnancy and implantation rates in period II (36.1 and
16.4%, respectively) were not lower than those (34.9 and
16.1%, respectively) in period I. The rate of triplet or more
gestations was significantly minimized in period II (2.3%)
compared to that in period I (26.5%).
Conclusions: We propose that determination of the date on
which embryos should be transferred based on the number
and quality of embryos on day 2 may help to maintain an
acceptable pregnancy rate, while minimizing embryo transfer
failure and high-order multiple gestations.
KEY WORDS: coculture; 2-day embryo quality; blastocyst trans-
fer; multiple gestations.
INTRODUCTION
The transfer of early cleavage-stage embryos on day
2 or day 3 is a common practice in assisted repro-
ductive technology programs. This procedure results
in implantation rates of 20% or less, so that many
clinics transfer two embryos or more to obtain ac-
ceptable pregnancy rates (1). The pregnancy rate in-
creases with the number of embryos transferred, but
so does the incidence of multiple gestations. Recently,
higher pregnancy and implantation rates have been
reported with the transfer of blastocyst-stage embryos
than with the transfer of cleavage-stage embryos (2,3).
These high implantation rates could allow transfer-
ring fewer embryos, thus avoiding the risk of multiple
pregnancies.
However, the main problem of blastocyst-stage
embryo transfer in human IVF-ET programs is the
possibility of embryo transfer failure: that is, there
were some patients who failed to produce blastocyst-
stage embryos and had no embryos to replace.
Therefore, it is questionable whether the transfer of
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blastocyst-stage embryos is beneficial in all infertile
patients. If the transfer of blastocyst-stage embryos
is performed in patients with a poor prognosis, it
might significantly reduce the chance of pregnancy.
Jones et al. (4) reported that the number of blastocyst-
stage embryos developing from the zygote stage was
positively influenced by the number of oocytes or
zygotes and the number of embryos developing to
the eight-cell stage or more. Also, good results from
5-day transfer cycles were achieved when the patients
had eight or more embryos on day 2 after fertiliza-
tion (5). Milki et al. (6) suggested that the transfer of
blastocyst-stage embryos should be performed only
in patients in whom the number of eight-cell stage
embryos on day 3 was three or more.
Beginning in January 1997, to reduce the possibil-
ity of high-order multiple gestations and the failure
of embryo transfer, embryo culture extended to day
5 was performed for patients at high risk for multi-
ple gestations. Transfers of blastocyst-stage embryos
were selectively performed only in patients who had
more than seven zygotes or two or more good-quality
2-day embryos. An early decision on the date of em-
bryo transfer, on day 2, may help to offer patients
plenty of time to travel for the replacement of their
embryos.
This study was carried out to compare alternative
embryo transfer in period II with routine cleavage-
stage embryo transfer in period I in terms of the im-
plantation, pregnancy, and multiple gestation rates,
resulting from the determination of their replace-
ment date based on the number and quality of 2-day
embryos.
MATERIALS AND METHODS
This study was carried out in 5732 cycles that pro-
duced more than one cleavage-stage embryo from
May 1996 to December 1998. The data were analyzed
in two periods. The 3-day embryo transfers (1032 cy-
cles) were routinely performed from May 1996 to
December 1996 (period I). In period II (from January
1997 to December 1998), the embryo transfers (4700
cycles) were performed on either day 3 or day 5 (oc-
casionally on day 6) by determination of the embryo
transfer date in accordance with the number and qual-
ity of 2-day embryos. During both periods, the meth-
ods used for ovarian stimulation, embryo culture, and
embryo cryopreservation were identical. The study
protocol was approved by the Institutional Review
Board.
Stimulation Protocol
Ovarian stimulation was performed using FSH
(Metrodin; Serono, Geneva, Switzerland) or hMG
(Humegon; Organon Pharmaceuticals, Saint Denis,
France) with gonadotropin releasing hormone ago-
nist (Superfact, Allemagne, Germany). When two fol-
licles reached 18 mm in diameter, a dose of 10,000 IU
of hCG (Profasi; Serono) was administered. Oocytes
were retrieved transvaginally 36–38 hr after hCG
injection.
Embryo Culture
All zygotes were cocultured with cumulus cells in
10„l of YS medium (Table I) supplemented with 10%
hFF for 48 or 96 hr. The hFF used in the present
study was prepared using the method reported by
Chi et al. (7). Cumulus cell pools were also prepared
from cumulus–oocyte complexes which were washed
three times immediately after oocyte collection. The
portions of the cell mass which were unclear out-
side the corona radiata of cumulus–oocyte complexes
were removed using two pieces of a 30-gauge needle.
Then only corona radiator masses from the cleaned
cumulus–oocyte complexes were excised using two
pieces of a 30-gauge needle. Oocytes with one or more
layers were cultured in 1 ml of YS medium contain-
ing 10% hFF for insemination. On the other hand,
the corona radiator masses were treated with 100 to
150„l of YS medium containing 10% hFF and 0.003%
Table I. Components of YS Medium Compared to G1, G2, and
P1 Media
Chemical G1 G2 P1 YSa
EDTA 0.10 — — 0.05
CaCl2 1.80 1.80 2.04 1.80
NaCl 85.16 85.16 101.60 110.00
KCl 5.50 5.50 4.70 5.00
NaH2PO4 0.50 0.50 — —
MgSO4 1.00 1.00 0.20 0.80
Na-citrate (mg/L) — — 0.15 —
Taurine 0.10 — 0.05 0.20
Na-pyruvate 0.32 0.10 0.33 0.40
Glucose 0.50 3.15 — —
KHCO3 — — — 5.00
NaHCO3 25.00 25.00 25.00 20.00
L-Glutamine 1.00 1.00 — 1.20
Na-lactate (DL) 21.00 11.74 21.40 3.00
MEM nonessential AA 10 ml/L 10 ml/L — 10 ml/L
RPMI 1640 AA — — — 10 ml/L
MEM essential AA — 10 ml/L — —
MEM vitamins — — — 5 ml/L
Antibiotics P/S P/S Gt P/S
a All components of YS medium were contained in 1 kg of distilled
water.
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hyaluronidase for lysis of gap junctions, resulting in a
change of the corona radiator masses to a pool con-
taining many single cells. The cumulus cell layers used
for coculture were made in 10-„l droplets by seeding
cumulus cells (1£ 104) obtained from the pool using a
pipette. After 4 hr of incubation, YS medium contain-
ing 0.003% hyaluronidase was exchanged with a pre-
equilibrated culture medium, and then the drop dishes
containing cumulus layers were incubated overnight.
All zygotes were cocultured with cumulus cells in 10„l
of YS medium containing 10% hFF for 48 or 96 hr. All
droplets for coculture were exchanged for a preequili-
brated culture medium every morning until day 6. At
the time of each medium change, only 5„l of medium
was removed from the coculture droplet, and then an
equal volume of a preequilibrated fresh medium was
added to it.
Determination of the Embryo Transfer Date
In period II, embryos were transferred on either
day 3 or day 5. The date of embryo transfer was de-
termined by the number of zygotes and the quality
of 2-day embryos. On day 2 after insemination, the
embryos were classified into four grades: embryos
which reached the four-cell or more stage and had
no cytoplasmic fragments (grade 1); embryos which
reached the four-cell or more stage but had less than
20% cytoplasmic fragments or embryos which did not
develop to the four-cell stage but had no cytoplas-
mic fragments (grade 2); embryos which developed
to the four-cell or more stage but had 20–50% cyto-
plasmic fragments or embryos which did not reach
the four-cell stage but had less than 50% cytoplasmic
fragments (grade 3); and embryos which did not reach
the four-cell stage and had more than 50% cytoplas-
mic fragments (grade 4). Grade 1 and grade 2 embryos
were regarded as good-quality embryos, while grade
3 and grade 4 embryos were considered as poor qual-
ity. Day 5 transfer was performed in patients (age,
<40 years) who had more than seven zygotes or two
or more good-quality embryos regardless of the num-
ber of zygotes in period II. The remaining patients
were allotted to day 3 transfer cycles. All patients who
were more than 40 years old also had 3-day cleavage-
stage embryos replaced, regardless of the number and
quality of the 2-day embryos, due to the possibility of
their not producing blastocyst-stage embryos in vitro.
The number of embryos transferred was determined
as below by depending upon the age of the patient,
the patient history, and the present embryo quality.
In general, a maximum of four embryos at the cleav-
age stage was replaced for day 3 transfer, while two
embryos at the blastocyst stage were used for day 5
transfer. In the blastocyst-stage embryos selected for
day 5 transfer, the inner cell mass and trophectoderm
cells were clear.
After embryo transfer, regardless of the transfer
date, surplus embryos were cultured until day 6, and
embryos developing to the expanded blastocyst stage
were cryopreserved by Menezo’s method III (8).
Statistical Analysis
Statistical analysis was performed using the ´2
test. A P value <0.05 was considered statistically
significant.
RESULTS
Five thousand seven hundred thirty-two cycles were
included in this study. In the first period, all 1032 pa-
tients underwent day 3 transfer. In the second period,
4652 of 4700 patients underwent embryo transfer on
day 3 or day 5.
The mean age and the mean number of oocytes or
embryos obtained in period I were similar to those
in period II (Table II). The mean number of embryos
transferred per cycle in the second period was sig-
nificantly lower than that in the first period (2.9 §
0.6 and 3.7 § 0.5, respectively; P < 0.001). Although
the pregnancy and implantation rates were similar in
both periods (Table II), the multiple pregnancy rate
was significantly lower in the second period than in
Table II. Embryo Transfer Outcome in Period I Compared to
Period II
Period I Period II P
No. of cycles 1032 4700
Mean age § SD 34.2 § 4.4 34.7 § 3.9 NSa
Mean No. of oocytes 10.5 § 3.1 11.5 § 7.9 NS
§ SD
Mean No. of fertilized 6.8 § 4.5 7.1 § 4.9 NS
oocytes § SD
ET cycles 1032 4653
Mean No. of embryos 3.7 § 0.5 2.9 § 0.6 <0.001
transferred § SD
Mean No. of blastocysts 0.6 § 0.5 1.3 § 0.9
frozen § SD
Cycles with embryo 6.4 27.6 <0.001
freezing (%)
Implantation rate (%) 16.1 16.4 NS
Pregnancy rate (%) 34.9 36.1 NS
Multiple gestations (%) 49.6 30.7 <0.05
Triplet gestations (%) 13.3 2.3 <0.001
Quadruplet gestations (%) 3.2 0 <0.001
a Not significant.
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the first period (P< 0.05). Furthermore, 13.3% of the
pregnancies were triplets, and 3.2% were quadruplets,
in the first period. In contrast, only 2.3% of the preg-
nancies were triplets, and there were no quadruplet
pregnancies, in the second period. The mean number
of embryos frozen per retrieval in the second period
was 1.3 § 0.9, much higher than the 0.6 § 0.5 in the
first period. Consequently, significantly more patients
(27.6%) had embryos frozen in the second period than
in the first period (6.4%) (P < 0.001) .
The outcome of day 3 and day 5 transfers in the sec-
ond period is shown in Table III. Day 3 transfer cycles
were performed in 57% of the patients (2701 cycles),
while day 5 transfer cycles were carried out in 43% of
the patients (1999 cycles). However, blastocyst-stage
embryos were transferred in only 1952 of 1999 cycles
after 5 days of culture. The mean age, mean number
of oocytes, and mean number of embryos in the day
3 transfer cycles (34.8 § 4.0, 8.6 § 3.1, and 5.0 § 2.1,
respectively) were similar, despite the inclusion of pa-
tients who were more than 40 years old, to those (34.6
§ 3.9, 15.7 § 7.0 and 10.0 § 4.5, respectively) in the
day 5 transfer cycles. The rate of embryos develop-
ing to the blastocyst stage in the day 5 transfer cycles
was 52.8%. The embryos in 33 cycles (1.7%) failed
to develop to the blastocyst stage even by day 6, re-
sulting in the cancellation of embryo transfer. In 14
cycles, the day 5 embryo transfer was canceled de-
spite successful embryo development to the blasto-
Table III. Outcome of Day 5 Versus Day 3 Embryo Transfer in
Period II
Embryo transfer
Day 3 Day 5
No. of cycles 2701 1999
Mean age § SD 34.8 § 4.0 34.6 § 3.9
Mean No. of oocytes § SD 8.6 § 3.1 15.7 § 7.0
Mean No. of fertilized 5.0 § 2.1 10.0 § 4.5
oocytes § SD
% blastocysts per 2PNs — 52.8
ET cycles 2701 1952a
Mean No. of embryos 3.4 § 0.9 2.3 § 0.5
transferred § SD
Mean No. of blastocysts 0.4 § 0.6 3.1 § 1.0
frozen § SD
Cycles with embryo 1.3 63.1
freezing (%)
Implantation rates (%) 13.1 23.2
Pregnancy rates (% per ET) 28.6 47.1
Multiple gestations (%) 31.0 30.4
Triplet gestations (%) 3.9 0.8
a Embryo transfer for 14 patients was canceled despite success-
ful embryo development to the blastocyst stage, and all their
embryos developing to the blastocyst stage were frozen for the
prevention of OHSS.
cyst stage, and embryos reaching the blastocyst stage
were frozen due to the risk of ovarian hyperstimu-
lation syndrome (OHSS). The mean number of em-
bryos transferred per cycle in day 5 transfer cycles was
significantly lower than that in day 3 transfer cycles
(2.3 § 0.5 vs 3.4 § 0.9), although the mean numbers
of oocytes or embryos per cycle in day 5 transfer cy-
cles were higher than those in day 3 transfer cycles.
On the other hand, many more embryos were frozen
at the blastocyst stage in day 5 transfer cycles than in
day 3 transfer cycles (3.1 § 1.0 and 0.4 § 0.6, respec-
tively), although we might consider the proportion to
the mean numbers of oocytes or embryos per cycle.
The pregnancy and implantation rates in day 5 trans-
fer cycles (47.1 and 23.2%, respectively) were signif-
icantly higher than in day 3 transfer cycles (28.6 and
13.1%, respectively), while the multiple pregnancy
rate in day 5 transfer cycles was similar to that in day 3
transfer cycles (30.4 and 31.0%, respectively). On the
other hand, the triplet pregnancy rate was reduced in
day 5 transfer cycles compared to day 3 transfer cycles
(0.8 and 3.9%, respectively). Consequently, the rate
of pregnancies with triplets or more in period II was
significantly decreased compared to that in period I
(Table II vs Table III).
DISCUSSION
This study demonstrates that the choice of embryo
transfer date is important for maintaining a constant
pregnancy rate, while decreasing multiple gestations
and embryo transfer failures. Multiple gestations, es-
pecially triplets or more, are one of the most serious
issues in assisted reproductive technology. According
to the American Society of Reproductive Medicine–
Society for Assisted Reproductive Technology report
(1995), 7% of deliveries are triplet-or-more gesta-
tions (9). There is no doubt that blastocyst transfer
is a way of eliminating high-order multiple pregnan-
cies, due to the decreased number of embryos trans-
ferred. However, the current culture systems may still
be suboptimal for supporting later preimplantation
development, although new culture systems and me-
dia are currently being developed. In previous studies
using coculture (10), a single culture medium (11), or
sequential media (12), there were no embryos that
reached the blastocyst stage in 8.5%, 28%, and 8.9%
of patients. Furthermore, Scholtes et al. (13) reported
that, of 929 patients in their first cycles, 545 (59%)
had at least one blastocyst-stage embryo available for
transfer, and thus 41% of the patients failed to transfer
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a blastocyst-stage embryo. Despite the recent encour-
aging results from the transfer of blastocyst-stage em-
bryos (2,3,11), embryo transfer failure is the main
reason why the transfer of blastocyst-stage embryos
cannot become an established protocol. Quinn et al.
(14) suggested that the embryos should be replaced
in the reproductive tract as soon as possible if pa-
tients have a small number of embryos. To reduce not
only the possibility of high-order multiple gestations
but also the failure of embryo transfer, we encour-
aged patients with more than seven zygotes or two
or more good embryos to undergo day 5 transfer and
the remainder to undergo day 3 transfer. Only 1.7%
of patients in day 5 transfer cycles failed to transfer
a blastocyst-stage embryo, and the rates of multiple
gestations and triplet gestations were significantly re-
duced when blastocyst-stage transfer was performed
for patients with large numbers of zygotes and good-
quality embryos. Furthermore, there were no ongoing
quadruplet pregnancies in the second period.
Patton et al. (15) reported that blastocyst-stage em-
bryo transfer cycles had higher implantation and preg-
nancy rates compared with day 3 embryo transfer
cycles in similar patient populations. In the present
study, it is unclear whether the implantation and preg-
nancy rates in the blastocyst-stage embryo transfer
cycles are higher than those in day 3 embryo transfer
cycles in similar patient populations. In the case of a
large number of oocytes, zygotes, or good-quality em-
bryos, it might be a natural result that the implantation
and pregnancy rates were higher in day 5 than in day 3
embryo transfer cycles. However, we found no differ-
ence in the pregnancy and implantation rates between
the two periods. There were no statistically significant
differences in the mean patient age or the mean num-
ber of oocytes or zygotes between the two periods.
It is important that similar pregnancy rates were ob-
served despite the transfer of significantly fewer em-
bryos. Therefore, in the traditional day 2 or day 3 em-
bryo transfer cycles, it is possible that embryos with a
high implantation potential are replaced to the uterus,
increasing the risk of high-order multiples without im-
proving the pregnancy rate.
It is interesting to note that significantly more cy-
cles had embryos frozen in the second period than in
the first period. In our previous report (16), the im-
plantation and ongoing pregnancy rates for frozen–
thawed blastocysts (21.2 and 38.7%, respectively)
were similar to those for fresh blastocysts (23.1 and
36.6%). Consequently, the cumulative pregnancy rate
per oocyte collection must be increased by frozen–
thawed blastocyst transfer.
Using the culture conditions described in the
present study, 52.8% of all zygotes developed to
the blastocyst stage, when cultured until day 6. YS
medium was designed to support the development of
human zygotes to the blastocyst stage in a coculture
system with cumulus cells. YS medium contains vi-
tamins, amino acids, and taurine and omits glucose
and phosphate (see Table I). It also contains much
more potassium and less lactate compared to G1/G2
or P1 media. Coats et al. (17) showed that the cul-
ture of human embryos in a glucose-free medium ver-
sus a medium containing 5.5 mM glucose did not im-
prove pregnancy rates. Conaghan et al. (18), however,
reported that there was an increase in the develop-
ment and blastocyst cell numbers in human embryos
cultured in a glucose-free compared with a glucose-
containing media. We also found that 2.5 to 5.5 mM
glucose was detrimental to the development of hu-
man embryos (unpublished data). Ludwig et al. (19)
found that a low level of glucose (0.5 mM), despite
causing little overt improvement in development up
to the blastocyst stage, significantly increased the pro-
portion of the fetus formed from the transfer embryos.
Under our culture conditions, with 10% hFF added
to the glucose-free YS medium as a protein source,
the embryos were exposed to a lower level of glucose
compared to that in other standard culture media. The
mean glucose concentration in hFF is in the range of
3.3–5.5 mM (20).
We found a positive correlation between the qual-
ity of embryos on day 2 or day 3 and their potential to
develop to the blastocyst stage in vitro (unpublished
data). Similar results have been reported by Sapiro
et al. (21), who observed that embryos reaching the
four-cell stage by day 2 are twice or more as likely to
develop to the blastocyst stage than slower-growing
embryos. Twin gestations are normally considered ac-
ceptable, while triplets are associated with an increase
in perinatal morbidity and mortality. Therefore, we
carried out blastocyst-stage embryo transfer in pa-
tients with more than two good-quality embryos on
day 2. The minimum of eight zygotes was based on the
results showing 30–50% blastocyst formation (2,13).
In conclusion, determination of the day on which
embryos should be transferred based on the num-
ber of zygotes and the quality of embryos on day 2
may help to maintain an acceptable pregnancy rate,
while minimizing embryo transfer failure and high-
order multiple gestations. In the present study, a
36.1% pregnancy rate, a 2.3% triplet rate, and only
a 0.7% cancellation rate were obtained. On the other
hand, to omit triplet-or-more gestations as well as to
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maintain an acceptable pregnancy rate while mini-
mizing embryo transfer failure, it is suggested that a
maximum of two viable blastocyst-stage embryos be
replaced to the uterus, although we did not investigate
the variation of the multiple gestation rate according
to the number of blastocyst-stage embryos transferred
on day 5.
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